atbtherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- atbtherapeutics's estimated annual revenue is currently $5.1M per year.
- atbtherapeutics's estimated revenue per employee is $189,444
- atbtherapeutics's total funding is $66M.
Employee Data
- atbtherapeutics has 27 Employees.
- atbtherapeutics grew their employee count by 29% last year.
atbtherapeutics's People
| Name | Title | Email/Phone |
|---|
atbtherapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.6M | 17 | -6% | $82.2M | N/A |
#2 | $3.6M | 23 | 53% | $93.4M | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $5.4M | 35 | 13% | $38.9M | N/A |
#5 | $5.1M | 33 | 27% | $16.4M | N/A |
#6 | $17.4M | 112 | 33% | N/A | N/A |
#7 | $5.1M | 27 | 29% | $66.1M | N/A |
What Is atbtherapeutics?
atbtherapeutics is a pioneering biopharmaceutical company building a new line of attack against cancer. \n\natbtherapeutics has developed the atbody; a game-changer biologic format designed to broaden the therapeutic window of antibody-based therapies. \n\nOnly our proprietary and versatile plant-based atbiofarm technology enables single-step manufacturing of our novel class of therapeutic atbodies. \n\nThe resulting therapeutics offer a novel mechanism of action, avoiding major cancer cell resistance, and provide a promising, life-changing therapy for hard-to-treat and refractory cancer.
keywords:N/A
$66M
Total Funding
27
Number of Employees
$5.1M
Revenue (est)
29%
Employee Growth %
N/A
Valuation
N/A
Accelerator